What can we help you find?
A discussion on the management of BTK [Bruton tyrosine kinase] inhibitor toxicities based on longer-term experience.
Pharmacy Times® interviewed Tim Safley, MBA, the Program Director of Accreditation Commission for Health Care, on the value of a pharmacist in the LTC health care space.
student cafe
Pharmacy students are asked: How has the coronavirus disease 2019 (COVID-19) impacted your education, and how well do you feel prepared for the future?
Pharmacy Times® interviewed Cory Kidd, PhD, CEO and founder of Catalia Health, on the value of technology in innovating patient care in the field of specialty pharmacy.
Key opinion leaders consider their first-line therapy options for treatment-naïve patients with chronic lymphocytic leukemia.
Kimberly Erlich, Nurse Practitioner, Pacific Coast Psychiatric Associates & the Healthy Teen Project and Consulting Associate Faculty, Duke University School of Nursing, discusses considerations for pharmacogenomic testing in the pediatric population for behavioral health treatment.
Pharmacy Times spoke with Suzanne Soliman, PharmD, BCMAS, about how pharmacists can get involved on social media and use it to educate the public about the value of pharmacists.
Samir Balile, PharmD, the Clinical Pharmacy Program Manager of Giant Food, discusses the value of a pharmacist in their communities due to their accessibility when people need them most.
This Pharmacy Times Webcast—Tuesday, July 21, 2020; 7-8 pm EST—we will provide an overview of how the COVID-19 pandemic has impacted the treatment and management of patients with cancer.
Key opinion leaders discuss trials focusing on patient populations with newly diagnosed chronic lymphocytic leukemia (CLL).
Pharmacy Times spoke with Ali McBride, PharmD, MS, BCOP, FASHP, FAzPA, about how the drug niraparib could affect treatment options for patients with ovarian cancer.
Look for the full Managing Oral Oncolytics through COVID-19 Pharmacy Times Webinar on July 17, 2020, 8 pm EST.